C-type lectin domain family 1 member B

Summary
UniProt ID
Q9P126
Gene Symbol
  • CLEC1B
  • CLEC2
Organism
Homo sapiens (human)
External Links
GlyGen
Q9P126
PubChem
Q9P126
RaftProt
Q9P126
Annotation
Keyword
  • 3D-structure
  • Alternative splicing
  • Disulfide bond
  • Glycoprotein
  • Host-virus interaction
  • Lectin
  • Phosphoprotein
  • Receptor
  • Reference proteome
  • Signal-anchor
  • Transmembrane helix
Gene Ontology (GO)
Sequence
MQDEDGYITLNIKTRKPALISVGSASSSWWRVMALILLILCVGMVVGLVALGIWSVMQRNYLQGENENRTGTLQQLAKRFCQYVVKQSELKGTFKGHKCSPCDTNWRYYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIRWVGLSRQKSNEVWKWEDGSVISENMFEFLEDGKGNMNCAYFHNGKMHPTFCENKHYLMCERKAGMTKVDQLP
Glycosylation Sites
Displaying all 3 entries
Position Description PubMed ID GlyTouCan ID Source
68 N-linked (GlcNAc...) asparagine
120 N-linked (GlcNAc...) asparagine
134 N-linked (GlcNAc...) asparagine
Feature
  • ProtVista GlyGen : Glycosylation Site from GlyGen
  • ProtVista UniProt : Glycosylation Site from UniProt
Pathway
Displaying all 2 entries
Pathway Name Organism
GPVI-mediated activation cascade Homo sapiens
Heme signaling Homo sapiens
Disease
Displaying entries 1 - 10 of 66 in total
DO ID Disease Name Source
DOID:0040085 bacterial sepsis
DOID:0050387 nonpapillary renal cell carcinoma
DOID:0050651 atrioventricular septal defect
DOID:0060262 gallbladder disease
DOID:0080348 Alzheimer's disease 1
DOID:0090021 split hand-foot malformation 1
DOID:0110035 Alzheimer's disease 2
DOID:0110037 Alzheimer's disease 5
DOID:0110038 Alzheimer's disease 6
DOID:0110039 Alzheimer's disease 7

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024